Why Private Equity is Furious Over a Paper in a Dermatology Journal

The sudden, unexplained removal of a research paper on private equity firms buying dermatology practices has raised questions about corporate influence. KATIE HAFNER https://ift.tt/2OTEX4A https://ift.tt/2PXVRvp The New York Times Health Private Equity October 26, 2018 at 12:00AM